Know our latest updates and news
News & Events
Organicell Announces FDA Approval Of IND Application For The Use Of Zofin™ In The Treatment Of Chronic Obstructive Pulmonary Disease (COPD)
Read More
The Forgotten Ones. Will Long-Haulers Be The Next Public Health Crisis? A Live Online Discussion On Covid-19 Long-Haulers
Read More
Organicell™ Regenerative Medicine And Its Investigational Therapeutic Zofin™ Featured In Two National Publications Examining Potential Therapies For Covid-19 Long-Haulers
Read More
THERAPEUTICS FOR ‘COVID-19 LONG-HAULERS’ EXPLODING ONTO THE SCENE AS 2020 ENDS
Read More
WSJ: LONG-HAUL COVID PATIENTS PUT HOPE IN EXPERIMENTAL DRUGS
Read More
Organicell™ Regenerative Medicine, Inc. Becomes Current With SEC Reporting Requirements
Read More
WATCH: ORGANICELL’S CHIEF SCIENCE OFFICER DR. MARI MITRANI PROFILED ON FOX NEWS AFFILIATE IN DENVER TO TALK ABOUT INVESTIGATIONAL DRUG ZOFIN AND ITS POTENTIAL EFFECTIVENESS FOR COVID-19.
Read More
SAVANNAH, GA DOCTOR PROVIDING TREATMENT FOR LONG-TERM COVID-19 EFFECTS
Read More
Organicell Announces Additional Site For Phase I/II Clinical Trial Of ZofinTM For Treatment Of COVID-19
Read More